Is the Answer in the Biopsy? Predicting 12-Month RRT Outcomes in Renal Thrombotic Microangiopathy
The prognostic value of quantitatively assessed histologic lesions in biopsy-proven renal thrombotic microangiopathy (TMA) remains poorly defined. We retrospectively evaluated 37 adults with biopsy-proven renal TMA to identify clinical and histologic predictors of renal replacement therapy (RRT) dependence at 12 months. At presentation, 18 patients (48.6%) required RRT, and 17 (45.9%) remained RRT-dependent at 12 months. Patients with persistent RRT dependence had higher peak serum creatinine (sCr) (8.97 ± 3.91 vs. 4.78 ± 2.20 mg/dL; p < 0.001) and greater proteinuria at diagnosis (5828 vs. 1365 mg/g; p = 0.004). Peak sCr showed the strongest discrimination for 12-month RRT dependence (AUC 0.815; cutoff 7.6 mg/dL). Among histologic variables, global glomerulosclerosis showed the best discrimination (AUC 0.725; cutoff ≥ 8%), whereas other TMA-associated lesions had limited prognostic value. In multivariable analysis, both peak sCr (OR 1.74, 95% CI 1.16–2.62; p = 0.008) and global glomerulosclerosis ≥ 8% (OR 8.76, 95% CI 1.23–62.40; p = 0.030) were independently associated with 12-month RRT dependence. Adding global glomerulosclerosis ≥ 8% significantly improved model fit compared with peak sCr alone (likelihood-ratio test, p = 0.016), increasing the apparent AUC from 0.815 to 0.868.
Authors
- Sheila Bermejo (ORCID: https://orcid.org/0000-0002-3611-4830)
- Zaira Castañeda (ORCID: https://orcid.org/0000-0001-7526-1078)
- Oriol Bestard (ORCID: https://orcid.org/0000-0001-9468-7920)
- Maria Antonieta Azancot (ORCID: https://orcid.org/0000-0002-8447-1373)
- Natalia Ramos-Terrades (ORCID: https://orcid.org/0000-0001-9832-326X)
- María José Soler (ORCID: https://orcid.org/0000-0003-3621-0766)
- Juan Carlos León-Román (ORCID: https://orcid.org/0000-0001-8058-1834)
- Irene Agraz (ORCID: https://orcid.org/0000-0002-4223-6834)
- Néstor Toapanta (ORCID: https://orcid.org/0000-0001-5983-6863)
- Alejandra Gabaldón (ORCID: https://orcid.org/0000-0002-0149-6955)
- Sara Núñez-Delgado (ORCID: https://orcid.org/0000-0002-3481-2520)
- Marina López-Martínez (ORCID: https://orcid.org/0000-0003-4284-831X)
- Marc Patricio-Liébana (ORCID: https://orcid.org/0000-0002-9669-0071)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Vall d'Hebron Hospital Universitari (ES)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3390/ijms272210320
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00